Financial Summary (All financials)
In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
Revenues | 12,698.6 | 10,323.0 | 8,856.3 | 8,918.9 | 8,930.2 | 8,187.6 | 7,503.7 | 7,824.3 |
Revenue growth | 23.0% | 16.6% | -0.7% | -0.1% | 9.1% | 9.1% | -4.1% | -25.0% |
Cost of goods sold | 9,338.5 | 7,186.1 | 5,858.1 | 5,975.5 | 6,189.5 | 5,751.5 | 5,177.3 | 5,598.2 |
Gross profit | 3,360.1 | 3,136.9 | 2,998.2 | 2,943.4 | 2,740.7 | 2,436.1 | 2,326.4 | 2,226.1 |
Gross margin | 26.5% | 30.4% | 33.9% | 33.0% | 30.7% | 29.8% | 31.0% | 28.5% |
Selling, general and administrative | 900.6 | 828.4 | 775.9 | 750.0 | 760.8 | 713.5 | 683.8 | 773.0 |
Research and development | 102.9 | 93.5 | 83.9 | 72.9 | 64.5 | 57.6 | 71.8 | 76.4 |
EBITA | 2,929.5 | 2,635.9 | 2,570.7 | 2,447.4 | 2,170.4 | 1,856.2 | 1,738.9 | 1,589.6 |
EBITA margin | 23.1% | 25.5% | 29.0% | 27.4% | 24.3% | 22.7% | 23.2% | 20.3% |
Amortization of intangibles | 35.5 | 37.2 | 34.5 | 33.1 | 30.0 | 22.6 | 22.3 | 24.0 |
EBIT | 2,894.0 | 2,598.7 | 2,536.2 | 2,414.3 | 2,140.4 | 1,833.6 | 1,716.6 | 1,565.6 |
EBIT margin | 22.8% | 25.2% | 28.6% | 27.1% | 24.0% | 22.4% | 22.9% | 20.0% |
Pre-tax income | 2,754.7 | 2,507.4 | 2,423.8 | 2,289.5 | 2,015.0 | 1,416.1 | 1,554.6 | 1,266.1 |
Income taxes | 500.8 | 462.8 | 478.4 | 480.1 | 524.3 | 260.9 | 432.6 | 300.2 |
Tax rate | 18.2% | 18.5% | 19.7% | 21.0% | 26.0% | 18.4% | 27.8% | 23.7% |
Earnings from continuing ops | 2,253.9 | 2,044.6 | 3,890.8 | 1,809.4 | 1,490.7 | 1,155.2 | 2,244.0 | 965.9 |
Earnings from discontinued ops | 12.6 | 70.3 | -14.3 | | 42.2 | 1,866.0 | -460.5 | 351.7 |
Net income | 2,266.5 | 2,114.9 | 3,876.5 | 1,809.4 | 1,532.9 | 3,021.2 | 1,783.5 | 1,317.6 |
Net margin | 17.8% | 20.5% | 43.8% | 20.3% | 17.2% | 36.9% | 23.8% | 16.8% |
|
Diluted EPS | $10.13 | $9.19 | $17.50 | $8.17 | $6.75 | $5.26 | $10.28 | $4.45 |
Shares outstanding (diluted) | 222.5 | 222.5 | 222.3 | 221.6 | 220.8 | 219.8 | 218.3 | 217.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|